Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerami, Akero, Armata, Astrazeneca, Bavarian Nordic, Beckley, Biontech, Bridgebio, Chemomab, Contrafect, Exelixis, Imago, Imbrium, Kempharm, Lexicon, Melt, Minovia, Mirata, Osivax, RQ, Sirnaomics, Small, Sosei, Vir, Viridian, Zynerba.